Welcome to your roundup of news and developments across the intellectual property landscape in Australia and New Zealand.
This edition of IP Spotlight brings good news for our client and innovators, as we report on the Australian Government’s additional research and development tax incentive. We also provide an update on pharmaceutical patent term extensions in Australia and report on a recent decision handed down by IP Australia in the case of Boehringer v Zoetis.
We hope you enjoy this informative publication, particularly at this time when travel and face-to-face networking continue to be limited.
